| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Happel David is a President &CEO at Sagimet Biosciences Inc.. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | SGMT Sagimet Biosciences Inc. | President &CEO | Sell | 65,478 | $9.13 | $598,115.34 | -8.7% | -11.3% | - | |
| Mar 26, 2024 | SGMT Sagimet Biosciences Inc. | President &CEO | Buy | 12,100 | $5.27 | $63,730.70 | +1.9% | -19.7% | -24.5% | |
| Dec 7, 2023 | SGMT Sagimet Biosciences Inc. | President &CEO | Buy | 1,600 | $4.10 | $6,560.00 | +0.3% | +65.1% | +26.2% | |
| Nov 16, 2023 | SGMT Sagimet Biosciences Inc. | President &CEO | Buy | 590 | $2.35 | $1,386.50 | New | +247.2% | +103.0% |